CN105362763A - 一种医治白血病的中药组合物及制法 - Google Patents
一种医治白血病的中药组合物及制法 Download PDFInfo
- Publication number
- CN105362763A CN105362763A CN201510867245.9A CN201510867245A CN105362763A CN 105362763 A CN105362763 A CN 105362763A CN 201510867245 A CN201510867245 A CN 201510867245A CN 105362763 A CN105362763 A CN 105362763A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- water
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims description 24
- 208000032839 leukemia Diseases 0.000 title abstract description 12
- 238000011282 treatment Methods 0.000 claims abstract description 33
- 210000000582 semen Anatomy 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 96
- 229940079593 drug Drugs 0.000 claims description 37
- 241000628997 Flos Species 0.000 claims description 29
- 241000233855 Orchidaceae Species 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 27
- 244000202566 Hydrocotyle vulgaris Species 0.000 claims description 26
- 235000015916 Hydrocotyle vulgaris Nutrition 0.000 claims description 26
- 241000209094 Oryza Species 0.000 claims description 26
- 235000007164 Oryza sativa Nutrition 0.000 claims description 26
- 235000009566 rice Nutrition 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 25
- 235000012907 honey Nutrition 0.000 claims description 21
- 230000008595 infiltration Effects 0.000 claims description 15
- 238000001764 infiltration Methods 0.000 claims description 15
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 13
- 238000002791 soaking Methods 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 239000011812 mixed powder Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 238000009738 saturating Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 12
- 230000004069 differentiation Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000298800 Actinidia arguta Species 0.000 abstract description 2
- 235000016416 Actinidia arguta Nutrition 0.000 abstract description 2
- 241000732800 Cymbidium Species 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 240000001548 Camellia japonica Species 0.000 abstract 1
- 241001632410 Eleutherococcus senticosus Species 0.000 abstract 1
- 241000208367 Euonymus Species 0.000 abstract 1
- 241000007039 Leucosceptrum canum Species 0.000 abstract 1
- 241000904512 Micromeria biflora Species 0.000 abstract 1
- 240000007930 Oxalis acetosella Species 0.000 abstract 1
- 235000008098 Oxalis acetosella Nutrition 0.000 abstract 1
- 235000018597 common camellia Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 16
- 210000001185 bone marrow Anatomy 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- 206010011224 Cough Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 6
- 208000007502 anemia Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 4
- 230000002607 hemopoietic effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000000366 juvenile effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010000830 Acute leukaemia Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000004103 basophilic normoblast Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 108010052008 colla corii asini Proteins 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000219066 Actinidiaceae Species 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001494508 Arundo donax Species 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000173256 Cymbidium kanran Species 0.000 description 1
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000208368 Euonymus alatus Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 239000002067 L01XE06 - Dasatinib Substances 0.000 description 1
- 239000005536 L01XE08 - Nilotinib Substances 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000208165 Oxalidaceae Species 0.000 description 1
- 240000007019 Oxalis corniculata Species 0.000 description 1
- 235000016499 Oxalis corniculata Nutrition 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000024207 chronic leukemia Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960002448 dasatinib Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000267 erythroid cell Anatomy 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229960001346 nilotinib Drugs 0.000 description 1
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种医治白血病的中药组合物,主要由下列原料药制备而成,均为质量份:泽泻7-13,米团花9-12,兰花叶6-13,小茜草8-14,水牛角7-12,软枣子5-11,姜味草7-14,山茶花6-12,吉祥草8-13,石莲子7-11,芦竹根6-14,野杜仲5-12,三叶铜钱草7-10,刺五加8-12。本发明所选中药材料,药源广,成本低,患者经济负担小,本组方根据中医辩证论治原则研制,有软坚化结、益气养血等功效,本发明疗效好,效果稳定,无明显毒副作用,值得推广。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种医治白血病的中药组合物及制法。
背景技术
白血病是造血系统的恶性肿瘤性疾病,又称“血癌”。造血细胞的某一系列、主要是某一白细胞系列的前体细胞失去分化成熟能力,在骨髓中和其他造血组织中呈恶性克隆性增生、积聚,并侵犯肝、脾、淋巴结,最终浸润破坏全身组织、器官,使正常造血功能受到抑制。白血病与实体肿瘤不同,不是生长在局部的赘生物,而是全身散播,可能侵犯各系统、器官和组织的恶性血液病。临床表现为贫血、出血、感染及各器官浸润症状。白血病在儿科恶性肿瘤的发病率中居第一位。其特点是骨髓及其他造血组织中有大量白血病细胞无限制地增生,并进入外周血液,而正常血细胞的制造被明显抑制。主要发生在骨髓及其他造血组织中,也可出现在全身其它组织中,致使正常的红系细胞、巨核系细胞显著减少。根据增生细胞类型,可分为粒细胞性、淋巴细胞性和单核细胞性三类。按白血病细胞分化程度可分为急性及慢性两大类。急性白血病发病急,骨髓和外周血中主要是原始细胞,若不治疗病人常于半年内死亡。患者常突感畏寒、发热、头痛、乏力、衰竭、食欲不振、恶心、呕吐、腹痛、腹胀,常有皮肤、鼻、口腔、齿龈出血,严重者可有呕血、便血、尿血、眼底及颅内出血等,并出现进行性贫血,发展极为迅速。慢性白血病起病缓慢,早期多无症状,常在看其他疾病验血时无意中发现。所以很多病人没有症状,尤其在早期的病人,随着疾病的进展,白血病破坏骨髓正常造血功能,浸润器官,引起了明显但非特异的症状。如贫血、反复感染且不易治好、出血倾向、脾大、不明原因的消瘦及盗汗等。
公布号CN101569720A(申请号200910102617.3)的中国专利文献公开了一种治疗白血病的苗药,原料药组成为黄芪、淫羊霍、乌桕、地黄、鱼腥草、黄精、杜仲、女贞、肿节风、五味子、石榴、无花果、山楂、猕猴桃、虎杖。公布号CN104825644A(申请号201510250320.7)的中国专利文献公开了一种治疗白血病的中药制剂,原料有来马回100-120,金银花50-60,白花蛇舌草50-60,半枝莲40-60,元参15-20,甘草15-20,当归100-120,阿胶20-30,藕粉10-20,糖粉5-10。公布号CN101979013A(申请号201010544963.X)的中国专利文献公开了一种治疗白血病的中药,中药组分为,黄芪4—10份;当归2—8份;阿胶4—10份;丹参3—9份;党参8—15份;熟地8—15份。
白血病病程长,病情易反复,增大了治疗难度,现有治疗白血病的方法有药物(如尼罗替尼、者达沙替尼),化疗和放疗,但这些方法副作用较大,且治愈率低,易复发,费用昂贵,并不适用于多数患者,中医学认为白血病的发病多在内在虚损、阴阳失和、脏腑虚弱的基础上温热毒邪等乘虚而人所致,可辩证论治或分型论治,提高机体的抗病能力,缓解白血病。
发明内容
针对现有技术的不足,本发明的目的是提供一种安全可靠、易久服的医治白血病的中药组合物及制法。
本发明的技术方案是:
一种医治白血病的中药组合物,主要由下列原料药制备而成,均为质量份:泽泻7-13,米团花9-12,兰花叶6-13,小茜草8-14,水牛角7-12,软枣子5-11,姜味草7-14,山茶花6-12,吉祥草8-13,石莲子7-11,芦竹根6-14,野杜仲5-12,三叶铜钱草7-10,刺五加8-12。
优选的方案中,泽泻9-11,米团花10-11,兰花叶8-11,小茜草10-12,水牛角8-11,软枣子7-9,姜味草9-12,山茶花8-10,吉祥草10-12,石莲子8-10,芦竹根8-12,野杜仲7-10,三叶铜钱草8-9,刺五加9-11
更加优选的,泽泻10,米团花10.5,兰花叶9.5,小茜草11,水牛角9.5,软枣子8,姜味草10.5,山茶花9,吉祥草10.5,石莲子9,芦竹根10,野杜仲8.5,三叶铜钱草8.5,刺五加10。
所述的一种医治白血病的中药组合物的汤剂的制备方法,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,小火煮20分钟,过滤,收集滤液;
(4)将泽泻、米团花、小茜草、姜味草、吉祥草、芦竹根、野杜仲和三叶铜钱草除去杂质,与步骤(1)(2)所制原料药一起加水煮,大火煮至沸腾后,小火煎34-46分钟(优选的,小火煎36-44分钟;更加优选的,小火煎40分钟),过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(5)将步骤(3)和(4)所制滤液合并,加热浓缩至原体积的二分之一,灭菌,即得汤剂。
所述的一种医治白血病的中药组合物汤剂的制备方法,步骤(4)所加水的量为所煮原料药质量的8-10倍(优选的,所加水的量为所煮原料药质量的9倍)。
所述的一种医治白血病的中药组合物的粉剂的制备方法,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,置于蒸锅内,隔水蒸透,取出,烘干;
(4)将米团花、小茜草、吉祥草、芦竹根、野杜仲和三叶铜钱草洗净,加水煎煮三次,每次所加水的量为所煮原料药质量的7倍,大火煮沸16-20分钟(优选的,大火煮沸17-19分钟;更加优选的,大火煮沸18分钟),过滤,合并三次煎煮所得药液,浓缩成清膏;
(5)将泽泻、姜味草和步骤(1)(2)(3)所制原料药一起烘干后粉碎过200目筛,制成药粉,与步骤(4)所制清膏混匀,烘干粉碎过筛,灭菌,即得粉剂。
所述的一种医治白血病的中药组合物粉剂的制备方法,步骤(5)粉碎过200-400目筛(优选的,粉碎过250-350目筛;更加优选的,粉碎过300目筛)。
所述的一种医治白血病的中药组合物的丸剂的制备方法,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,置于蒸锅内,隔水蒸透,取出,烘干;
(4)将米团花、小茜草、吉祥草、芦竹根、野杜仲和三叶铜钱草洗净,加水煎煮三次,每次所加水的量为所煮原料药质量的7倍,大火煮沸16-20分钟(优选的,大火煮沸17-19分钟;更加优选的,大火煮沸18分钟),过滤,合并三次煎煮所得药液,浓缩干燥,粉碎制成药粉;
(5)将泽泻、姜味草和步骤(1)(2)(3)所制原料药一起烘干后粉碎过120-160目筛(优选的,粉碎过130-150目筛;更加优选的,粉碎过140目筛),制成药粉,与步骤(4)所制药粉混匀,制得混合药粉,将所制混合药粉加炼蜜和水,泛制成丸,干燥,灭菌,即得丸剂。
所述的一种医治白血病的中药组合物丸剂的制备方法,步骤(5)炼蜜的量为混合药粉质量的0.2-0.3倍(优选的,炼蜜的量为混合药粉质量的0.25倍)。
所述的一种医治白血病的中药组合物的煎膏剂的制备方法,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉,粉碎制成药粉;
(3)将泽泻、米团花、小茜草、姜味草、吉祥草、野杜仲和三叶铜钱草除去杂质,与步骤(1)所制原料药一起加水煮(水的量为所煮原料药质量的7倍),大火煮至沸腾后,小火煎34-46分钟(优选的,小火煎36-44分钟;更加优选的,小火煎40分钟),过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(4)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子、山茶花和芦竹根一起捣碎,加步骤(3)所制滤液,加热煮,熬成清膏,加炼蜜拌匀,制成稠膏,关火,撒入步骤(2)所制药粉搅拌混匀,灭菌,即得煎膏剂。
所述的一种医治白血病的中药组合物煎膏剂的制备方法,步骤(4)稠膏的相对密度为1.21-1.27(60℃)(优选的,稠膏的相对密度为1.23-1.25;更加优选的,稠膏的相对密度为1.24)。
本发明提供的一种医治白血病的中药组合物配伍严谨,制备科学,产品安全。除此之外,本发明的优良效果还表现在:
1、本发明所选中药材料,药源广,成本低,患者经济负担小;
2、本组方根据中医辩证论治原则研制,有软坚化结、益气养血等功效;
3、本发明疗效好,效果稳定,无明显毒副作用,值得推广。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1一种医治白血病的中药组合物,主要由下列原料药制备而成(每份10g):泽泻7份,米团花9份,兰花叶6份,小茜草8份,水牛角7份,软枣子5份,姜味草7份,山茶花6份,吉祥草8份,石莲子7份,芦竹根6份,野杜仲5份,三叶铜钱草7份,刺五加8份。
上述一种医治白血病的中药组合物汤剂的制备方法是:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,小火煮20分钟,过滤,收集滤液;
(4)将泽泻、米团花、小茜草、姜味草、吉祥草、芦竹根、野杜仲和三叶铜钱草除去杂质,与步骤(1)(2)所制原料药一起加水煮(所加水的量为所煮原料药质量的9倍),大火煮至沸腾后,小火煎40分钟,过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(5)将步骤(3)和(4)所制滤液合并,加热浓缩至原体积的二分之一,灭菌,即得汤剂。
实施例2一种医治白血病的中药组合物,主要由下列原料药制备而成(每份10g):泽泻13份,米团花12份,兰花叶13份,小茜草14份,水牛角12份,软枣子11份,姜味草14份,山茶花12份,吉祥草13份,石莲子11份,芦竹根14份,野杜仲12份,三叶铜钱草10份,刺五加12份。
一种医治白血病的中药组合物粉剂的制备方法是:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,置于蒸锅内,隔水蒸透,取出,烘干;
(4)将米团花、小茜草、吉祥草、芦竹根、野杜仲和三叶铜钱草洗净,加水煎煮三次,每次所加水的量为所煮原料药质量的7倍,大火煮沸18分钟,过滤,合并三次煎煮所得药液,浓缩成清膏;
(5)将泽泻、姜味草和步骤(1)(2)(3)所制原料药一起烘干后粉碎过200目筛,制成药粉,与步骤(4)所制清膏混匀,烘干粉碎过300目筛,灭菌,即得粉剂。
典型病例:xxx,女,63岁。主诉:近三个月,反复出现头昏、乏力,恶心呕吐一周,加重两天,医院检查,面色惨白,重度贫血貌,胸骨压痛,手足心热,气促,纳呆,舌淡,苔白,脉沉细,骨髓象检查确诊为慢性粒细胞性白血病,住院治疗,症状仍反复发作,遂转入中医院治疗。
服用本实施例所得一种医治白血病的中药组合物粉剂,每天2次,每次4-6g,温开水送服,28天一个疗程。服用两周后,诸症明显减轻,服用两个疗程后,食量增加,面色改善,血象改善,服用四个疗程后,患者可正常活动,外周血象和骨髓象各项指标均接近正常,患者完全缓解,一年随访未见反复。
实施例3一种医治白血病的中药组合物,主要由下列原料药制备而成(每份10g):泽泻9份,米团花10份,兰花叶8份,小茜草10份,水牛角8份,软枣子7份,姜味草9份,山茶花8份,吉祥草10份,石莲子8份,芦竹根8份,野杜仲7份,三叶铜钱草8份,刺五加9份。
一种医治白血病的中药组合物丸剂的制备方法是:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,置于蒸锅内,隔水蒸透,取出,烘干;
(4)将米团花、小茜草、吉祥草、芦竹根、野杜仲和三叶铜钱草洗净,加水煎煮三次,每次所加水的量为所煮原料药质量的7倍,大火煮沸18分钟,过滤,合并三次煎煮所得药液,浓缩干燥,粉碎制成药粉;
(5)将泽泻、姜味草和步骤(1)(2)(3)所制原料药一起烘干后粉碎过140目筛,制成药粉,与步骤(4)所制药粉混匀,制得混合药粉,将所制混合药粉加炼蜜(炼蜜的量为混合药粉质量的0.25倍)和水,泛制成丸,干燥,灭菌,即得丸剂。
典型病例:xxx,男,5岁。主诉:无明显诱因出现乏力,心悸,面色惨淡,县医院检查,中度贫血貌,颈及腹沟淋巴结肿大,外周血象显示有原始幼稚细胞,骨髓象检查,粒细胞系统增生减低,红细胞系统增生活跃,有巨幼样变,确诊为急性淋巴性白血病,治疗一个月因经济原因转入中医院治疗。
服用本实施例所得一种医治白血病的中药组合物丸剂,采用每天2次,每次4粒,用温开水送服,28天一个疗程。服用一个疗程后,精神好转,食量增加,服用两个疗程后,面有血色,乏力、心悸基本消除,可自由行动,服用四个疗程后,患者面色红润,能正常生活,血常规及骨髓象检查均在正常范围内,一年后随访患者身体状态正常,无反复。
实施例4一种医治白血病的中药组合物,主要由下列原料药制备而成(每份10g):泽泻11份,米团花11份,兰花叶11份,小茜草12份,水牛角11份,软枣子9份,姜味草12份,山茶花10份,吉祥草12份,石莲子10份,芦竹根12份,野杜仲10份,三叶铜钱草9份,刺五加11份。
一种医治白血病的中药组合物煎膏剂的制备方法是:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉,粉碎制成药粉;
(3)将泽泻、米团花、小茜草、姜味草、吉祥草、野杜仲和三叶铜钱草除去杂质,与步骤(1)所制原料药一起加水煮(水的量为所煮原料药质量的7倍),大火煮至沸腾后,小火煎40分钟,过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(4)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子、山茶花和芦竹根一起捣碎,加步骤(3)所制滤液,加热煮,熬成清膏,加炼蜜拌匀,制成相对密度为1.24(60℃)的稠膏,关火,撒入步骤(2)所制药粉搅拌混匀,灭菌,即得煎膏剂。
典型病例:xxx,男,33岁。主诉:近一个月出现咳嗽、乏力,高热3天,医院检查,精神差,全身皮肤粘膜未见黄染和出血点,全身浅淋巴结无肿大,胸骨压痛,双肺呼吸音粗,舌质红,苔白,脉细滑,血红蛋白114g/L,血白细胞10.2×109/L,幼稚细胞占64%,骨髓象确诊为急性粒细胞白血病。
患者采用APL化疗,并服用本实施例所得一种医治白血病的中药组合物煎膏剂,采用每天2次,每次5-10ml,用温开水冲服,28天一个疗程。服用一个疗程后,高热消退,患者精神好转,咳嗽基本消除,服用两个疗程后,患者面有血色,食量增加,可下床活动,服用三个疗程后,患者完全缓解,无不适症状,一年后随访无复发。
实施例5一种医治白血病的中药组合物,主要由下列原料药制备而成(每份10g):泽泻10份,米团花10.5份,兰花叶9.5份,小茜草11份,水牛角9.5份,软枣子8份,姜味草10.5份,山茶花9份,吉祥草10.5份,石莲子9份,芦竹根10份,野杜仲8.5份,三叶铜钱草8.5份,刺五加10份。
一种医治白血病的中药组合物汤剂的制备方法是:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,小火煮20分钟,过滤,收集滤液;
(4)将泽泻、米团花、小茜草、姜味草、吉祥草、芦竹根、野杜仲和三叶铜钱草除去杂质,与步骤(1)(2)所制原料药一起加水煮(所加水的量为所煮原料药质量的9倍),大火煮至沸腾后,小火煎40分钟,过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(5)将步骤(3)和(4)所制滤液合并,加热浓缩至原体积的二分之一,灭菌,即得汤剂。
本发明所用主要中药原料的药理如下:
泽泻:基原:为泽泻科植物泽泻的块茎。性味:甘,寒。归经:归肾、膀胱经。功能主治:利小便,清湿热。用于小便不利,水肿胀满,泄泻尿少,痰饮眩晕,热淋涩痛,高血脂。
米团花:基原:为唇形科植物蜂蜜树的叶或根皮。性味:味苦,性凉。功能主治:清热解毒,利湿消肿,接骨止血。主高热无汗无名肿毒,黄水疮,附骨疽,跌打骨折,外伤出血。
兰花叶:基原:为兰科植物建兰,寒兰或台兰等的叶。性味:味辛,性微寒。归经:心,脾,肺经。功能主治:清肺止咳,凉血止血,利湿解毒。主肺痈,支气管炎,咳嗽,咯血,吐血,尿血,白浊,白带,尿路感染,疮毒疔肿。
小茜草:基原:为茜草科植物云南希草的地上部分。性味:甘,平。功能主治:补血活血,祛风除湿。主贫血,头晕失眠,风湿痹痛,慢性胃炎,跌打损伤,月经不调。
水牛角:基原:牛科动物水牛的角。性味:苦,寒。归经:归心、肝经。功能主治:清热解毒,凉血,定惊。用于温病高热,神昏谵语,发斑发疹,吐血衄血,惊风,癫狂。
软枣子:基原:为猕猴桃科植物软枣猕猴桃的果实。性味:甘,微酸,微寒。归经:胃经。功能主治:滋阴清热,除烦止渴,能淋。主热病津伤或阴血不足,烦渴引饮,砂淋,石淋,维生素C缺乏症,牙龈出血,肝炎,多作滋补营养剂。
姜味草:基原:为唇形科植物姜味草的全草。性味:辛,温。功能主治:祛风解表,温中除湿。用于感冒咳嗽,胃痛,急性胃肠炎,消化不良,腹胀,腹痛,疝气痛,预防痢疾。
山茶花:基原:为山茶科植物山茶的花。性味:辛、苦,寒。归经:入肝、肺二经。功能主治:收敛凉血,止血。用于吐血,衄血,便血,血崩,外用治烧烫伤,创伤出血。
吉祥草:基原:为百合科植物吉祥草的带根全草。性味:甘,平。功能主治:润肺止咳,祛风,接骨。用于肺结核,咳嗽咯血,慢性支气管炎,哮喘,风湿性关节炎,外用治跌打损伤,骨折。
石莲子:基原:为睡莲科植物莲老熟的果实。性味:甘、微苦,平。功能主治:健脾止泻。用于慢性痢疾,食欲不振。
芦竹根:基原:为禾本科植物芦竹的根茎。性味:苦,寒。功能主治:清热利水。治热病发狂,虚劳骨蒸,淋病,小便不利,风火牙痛。
野杜仲:基原:为卫矛科植物大花卫矛的根、根皮或树皮。性味:苦,辛,平。归经:脾,肝经。功能主治:祛风除湿,活血通经,化瘀散结。主风湿疼痛,跌打伤肿,腰痛,经闭,痛经,瘰疬痰核。
三叶铜钱草:基原:为酢浆草科植物白花酢浆草的全草。性味:味酸,微辛,性平。归经:心,肝,膀胱经。功能主治:活血化瘀,清热解毒,利尿通淋。主劳伤疼痛,跌打损伤,麻疯,无名肿毒,疥癣,小儿口疮,烫火伤,淋浊带下,尿闭。
刺五加:基原:为五加科植物刺五加的根、根茎或茎叶。性味:辛、微苦,温。归经:归脾、肾、心经。功能主治:益气健脾,补肾安神。用于脾肾阳虚,体虚乏力,食欲不振,腰膝酸痛,失眠多梦。
试验例1本发明所得一种医治白血病的中药组合物(实施例5)的临床应用:
2012年5月-2014年11月,在6所医院住院部收治的白血病患者中筛选出217例患者,其中女性88例,男性129例,年龄8-62岁,平均年龄(32.4±8.4)岁。其中急性白血病98例,急性髓细胞白血病44例,急性粒细胞白血病75例。
将患者随机分为两组,实验组125例和对照组92例,两组在性别、年龄、病程、病情等方面无显著差异(P>0.05),具有可比性。对照组采用常规化疗方案进行治疗,实验组在对照组的基础上,服用本发明所得产品,每天服用两次(温热),每次350m1-500m1(视具体情况有所调整),28天一个疗程。治疗期间对两组患者进行连续观察,记录症状及变化。
疗效情况判定标准:完全缓解(CR):白血病临床症状及体征消失,能够或接近正常生活,血红蛋白(男性≥100g/L,女性或儿童≥90g/L),中性粒细胞绝对值>1.5×109/L,骨髓象原始细胞加早幼阶段细胞(或幼稚细胞)<5%,红细胞系统及巨核细胞系统正常;部分缓解(PR):临床症状、血象及骨髓象三项中仅有一项或两项未达到缓解标准,骨髓象中原始细胞加早幼细胞<20%;未缓解(NR):临床症状、血象及骨髓象均未达到缓解标准,骨髓象中原始细胞加早幼细胞>20%。总有效率=(CR+PR)/(CR+PR+NR)×100%
表1两组患者治疗结果
经治疗,两组治疗结果如表1所示,实验组中,完全缓解患者68例,部分缓解51例,实验组治疗总有效率为95.2%,对照组中,完全缓解患者27例,部分缓解32例,对照组治疗总有效率为64.1%,两组治疗结果相比,可知实验组的治疗效果明显优于对照组,两组总有效率间存在显著性差异。
本发明选择有清湿热的泽泻,利湿消肿的米团花,清肺止咳的兰花叶,补血活血的小茜草,清热解毒的水牛角,滋阴清热的软枣子,温中除湿的姜味草,收敛凉血的山茶花,润肺止咳的吉祥草,健脾止泻的石莲子,清热利水的芦竹根,化瘀散结的野杜仲,活血化瘀的三叶铜钱草,益气健脾的刺五加,诸药合用,可奏软坚化结、益气养血等功效。
应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例,还可以有很多变形。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (10)
1.一种医治白血病的中药组合物,其特征在于,主要由下列原料药制备而成,均为质量份:泽泻7-13,米团花9-12,兰花叶6-13,小茜草8-14,水牛角7-12,软枣子5-11,姜味草7-14,山茶花6-12,吉祥草8-13,石莲子7-11,芦竹根6-14,野杜仲5-12,三叶铜钱草7-10,刺五加8-12。
2.如权利要求1所述的一种医治白血病的中药组合物,其特征在于,泽泻9-11,米团花10-11,兰花叶8-11,小茜草10-12,水牛角8-11,软枣子7-9,姜味草9-12,山茶花8-10,吉祥草10-12,石莲子8-10,芦竹根8-12,野杜仲7-10,三叶铜钱草8-9,刺五加9-11(优选的,泽泻10,米团花10.5,兰花叶9.5,小茜草11,水牛角9.5,软枣子8,姜味草10.5,山茶花9,吉祥草10.5,石莲子9,芦竹根10,野杜仲8.5,三叶铜钱草8.5,刺五加10)。
3.如权利要求1-2任一所述的一种医治白血病的中药组合物的汤剂的制备方法,其特征在于,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,小火煮20分钟,过滤,收集滤液;
(4)将泽泻、米团花、小茜草、姜味草、吉祥草、芦竹根、野杜仲和三叶铜钱草除去杂质,与步骤(1)(2)所制原料药一起加水煮,大火煮至沸腾后,小火煎34-46分钟(优选的,小火煎36-44分钟;更加优选的,小火煎40分钟),过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(5)将步骤(3)和(4)所制滤液合并,加热浓缩至原体积的二分之一,灭菌,即得汤剂。
4.如权利要求3所述的一种医治白血病的中药组合物汤剂的制备方法,其特征在于,步骤(4)所加水的量为所煮原料药质量的8-10倍(优选的,所加水的量为所煮原料药质量的9倍)。
5.如权利要求1-2任一所述的一种医治白血病的中药组合物的粉剂的制备方法,其特征在于,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,置于蒸锅内,隔水蒸透,取出,烘干;
(4)将米团花、小茜草、吉祥草、芦竹根、野杜仲和三叶铜钱草洗净,加水煎煮三次,每次所加水的量为所煮原料药质量的7倍,大火煮沸16-20分钟(优选的,大火煮沸17-19分钟;更加优选的,大火煮沸18分钟),过滤,合并三次煎煮所得药液,浓缩成清膏;
(5)将泽泻、姜味草和步骤(1)(2)(3)所制原料药一起烘干后粉碎过200目筛,制成药粉,与步骤(4)所制清膏混匀,烘干粉碎过筛,灭菌,即得粉剂。
6.如权利要求5所述的一种医治白血病的中药组合物粉剂的制备方法,其特征在于,步骤(5)粉碎过200-400目筛(优选的,粉碎过250-350目筛;更加优选的,粉碎过300目筛)。
7.如权利要求1-2任一所述的一种医治白血病的中药组合物的丸剂的制备方法,其特征在于,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉;
(3)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子和山茶花一起捣碎,加炼蜜和水拌匀,置于蒸锅内,隔水蒸透,取出,烘干;
(4)将米团花、小茜草、吉祥草、芦竹根、野杜仲和三叶铜钱草洗净,加水煎煮三次,每次所加水的量为所煮原料药质量的7倍,大火煮沸16-20分钟(优选的,大火煮沸17-19分钟;更加优选的,大火煮沸18分钟),过滤,合并三次煎煮所得药液,浓缩干燥,粉碎制成药粉;
(5)将泽泻、姜味草和步骤(1)(2)(3)所制原料药一起烘干后粉碎过120-160目筛(优选的,粉碎过130-150目筛;更加优选的,粉碎过140目筛),制成药粉,与步骤(4)所制药粉混匀,制得混合药粉,将所制混合药粉加炼蜜和水,泛制成丸,干燥,灭菌,即得丸剂。
8.如权利要求7所述的一种医治白血病的中药组合物丸剂的制备方法,其特征在于,步骤(5)炼蜜的量为混合药粉质量的0.2-0.3倍(优选的,炼蜜的量为混合药粉质量的0.25倍)。
9.如权利要求1-2任一所述的一种医治白血病的中药组合物的煎膏剂的制备方法,其特征在于,步骤如下:
(1)取刺五加切片,与兰花叶一起和米拌匀,置于蒸锅内,隔水蒸至米六成熟时,取出,除去米,晾干;
(2)将水牛角洗净,温水浸泡2小时,镑刨成薄片,将蓖麻油置锅中熬至微沸,投入水牛角薄片,炸至酥脆取出晾凉,粉碎制成药粉;
(3)将泽泻、米团花、小茜草、姜味草、吉祥草、野杜仲和三叶铜钱草除去杂质,与步骤(1)所制原料药一起加水煮(水的量为所煮原料药质量的7倍),大火煮至沸腾后,小火煎34-46分钟(优选的,小火煎36-44分钟;更加优选的,小火煎40分钟),过滤,收集滤液,滤渣加水再煮,大火煮沸后小火煎30分钟,过滤,合并两次所得滤液;
(4)取石莲子用水浸润,去壳,与姜汁拌匀放置30分钟,再用文火炒至表面微黄取出,与软枣子、山茶花和芦竹根一起捣碎,加步骤(3)所制滤液,加热煮,熬成清膏,加炼蜜拌匀,制成稠膏,关火,撒入步骤(2)所制药粉搅拌混匀,灭菌,即得煎膏剂。
10.如权利要求9所述的一种医治白血病的中药组合物煎膏剂的制备方法,其特征在于,步骤(4)稠膏的相对密度为1.21-1.27(优选的,稠膏的相对密度为1.23-1.25;更加优选的,稠膏的相对密度为1.24)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510867245.9A CN105362763A (zh) | 2015-12-02 | 2015-12-02 | 一种医治白血病的中药组合物及制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510867245.9A CN105362763A (zh) | 2015-12-02 | 2015-12-02 | 一种医治白血病的中药组合物及制法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105362763A true CN105362763A (zh) | 2016-03-02 |
Family
ID=55365713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510867245.9A Pending CN105362763A (zh) | 2015-12-02 | 2015-12-02 | 一种医治白血病的中药组合物及制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105362763A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879758A (zh) * | 2006-05-16 | 2006-12-20 | 张仕金 | 用于治疗白血病的药物及其制备方法 |
CN101091736A (zh) * | 2006-06-22 | 2007-12-26 | 黑龙江省中医研究院 | 一种治疗肿瘤的中药组合物及其制备方法 |
CN102784315A (zh) * | 2011-12-07 | 2012-11-21 | 魏如庆 | 治疗慢性粒细胞白血病的中成药 |
-
2015
- 2015-12-02 CN CN201510867245.9A patent/CN105362763A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879758A (zh) * | 2006-05-16 | 2006-12-20 | 张仕金 | 用于治疗白血病的药物及其制备方法 |
CN101091736A (zh) * | 2006-06-22 | 2007-12-26 | 黑龙江省中医研究院 | 一种治疗肿瘤的中药组合物及其制备方法 |
CN102784315A (zh) * | 2011-12-07 | 2012-11-21 | 魏如庆 | 治疗慢性粒细胞白血病的中成药 |
Non-Patent Citations (2)
Title |
---|
宋素艳等: "《现代实用临床医学研究 中医学》", 30 June 2013, 知识产权出版社 * |
胡小勤等: "《中药学》", 31 January 2014, 西安交通大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104524287A (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法 | |
CN104771660A (zh) | 治疗胃癌的中药剂及制备方法 | |
CN104840773A (zh) | 治疗椎动脉型颈椎病的中药组合物及制法 | |
CN105362763A (zh) | 一种医治白血病的中药组合物及制法 | |
CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
CN104888182A (zh) | 一种治疗产后腹痛的中药制剂及其制备方法 | |
CN105012789A (zh) | 治疗宫颈癌的组合物及其制备方法 | |
CN105362887A (zh) | 治疗白血病的方剂及制备方法 | |
CN104435922A (zh) | 一种治疗动脉硬化的中药组合物 | |
CN104667049A (zh) | 治疗肺炎的中药制剂及制备方法 | |
CN104147166B (zh) | 败血症初期清凉解毒饮及制法 | |
CN113633707A (zh) | 一种治疗淋巴癌的中药汤剂及其制备方法 | |
CN105288272A (zh) | 治疗尿毒症的方剂及制备方法 | |
CN106309889A (zh) | 一种用于治疗慢性支气管炎的中药汤剂 | |
CN107582872A (zh) | 一种用于胸椎综合症的中药组合物及其制备方法 | |
CN105079565A (zh) | 治疗哮喘的方剂及制备方法 | |
CN105327028A (zh) | 治疗尿毒症的制剂及制法 | |
CN105106702A (zh) | 一种防治肺癌的润肺化痰制剂及制法 | |
CN105106800A (zh) | 一种治疗卵巢癌的制剂及其制备方法 | |
CN106237060A (zh) | 一种用于治疗慢性支气管炎的中药胶囊 | |
CN105477155A (zh) | 一种医治膝关节滑膜炎的中药贴及制备方法 | |
CN104645105A (zh) | 治疗因运动导致的血尿症的药物及制备 | |
CN105853637A (zh) | 对放化疗具有增效作用的中药组合物及制备方法 | |
CN104800740A (zh) | 适宜胃癌患者服用的药膳及制备方法 | |
CN105560834A (zh) | 颈椎病祛风散寒热敷盐及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: The big 038100 East Shanxi province Datong Yanggao County No. 71 Building No. 6 3-301 Applicant after: Zhao Guiying Address before: The central Shunyu road Ji'nan City, Shandong province 250000 City No. 12 Applicant before: Zhao Guiying |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160302 |